KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Asset Writedowns and Impairment (2016 - 2026)

Globus Medical filings provide 15 years of Asset Writedowns and Impairment readings, the most recent being -$5.8 million for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 174.95% to -$5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.2 million, a 56.24% decrease, with the full-year FY2025 number at $10.2 million, down 56.24% from a year prior.
  • Asset Writedowns and Impairment hit -$5.8 million in Q4 2025 for Globus Medical, down from $5.1 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $8.5 million in Q2 2024 to a low of -$5.8 million in Q4 2025.
  • Median Asset Writedowns and Impairment over the past 5 years was $3.2 million (2021), compared with a mean of $2.6 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 2095.43% in 2021 and later soared 4533.85% in 2024.
  • Globus Medical's Asset Writedowns and Impairment stood at -$4.4 million in 2021, then soared by 111.67% to $510000.0 in 2022, then soared by 735.1% to $4.3 million in 2023, then soared by 80.61% to $7.7 million in 2024, then tumbled by 174.95% to -$5.8 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were -$5.8 million (Q4 2025), $5.1 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.